Soleno Therapeutics, Inc. (NASDAQ: SLNO ) focuses on rare diseases, particularly PWS hyperphagia. This condition creates insatiable hunger in patients, severely affecting their quality of life. Unfortunately, there are no approved treatments for this condition. However, SLNO's leading drug candidate, DCCR, has effectively reduced hunger My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. deg ...